NEWS & EVENTS

  In the News

  Event Schedule
PRESS RELEASE
Monday November 27, 2006

Signalife Video Link to AHA Demonstration of Fidelity 100

GREENVILLE, S.C., Nov. 27 /PRNewswire-FirstCall/Signalife (AMEX: SGN) astonished participants at the AHA when Athletes for Life Founder Willie Gault performed a "sprinting" treadmill test while garnering a diagnostic quality ECG. Pamela Bunes commented by saying, "We have more to come," as people from all over the conference came to witness the demonstration of the Fidelity 100. Download PDF

 

Note: Please be patient. Slower connections may take longer to stream or download.
About Heart Tronics, Inc.
Heart Tronics, Inc. engages in the research, development, and marketing of signal-monitoring devices for detecting diseases. It primarily offers patient modules that are used as part of a heart monitor system to acquire, amplify, and process physiological signals associated with a patient’s cardiovascular system. Heart Tronics is based in Greenville, South Carolina. For more information visit http://www.Heart Tronics.com.

Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are “forward-looking” statements. Forward-looking statements involve known and unknown risks, which may cause Heart Tronics’s actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Heart Tronics’s technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Heart Tronics’s technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Heart Tronics’s technology, and the unavailability of financing to complete management’s plans and objectives, including the development of heart monitoring and other biomedical incorporating Heart Tronics’s technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Heart Tronics’s filings with the Securities and Exchange Commission.